Home›People›Kevin Roche
KR

Kevin Roche

Director at RxFunction.

DirectorPublic company
Updated Nov 9, 2026·Latest SEC filing Oct 14, 2026·Suggest an edit

About Kevin Roche

Kevin Roche is a director at RxFunction.

Kevin Roche reports to the SEC as a director of 4 public companies, including Tactile Systems Technology (TCMD), Cogentix Medical (CGNT) and Uroplasty (UPI).

Kevin Roche first appears on SEC filings in 2008.

Experience

This experience comes from SEC filings. The years are when the filings name Kevin Roche in the role, so the role may have started earlier or lasted longer.

RxFunction, Inc.
Director
2017 – 2026 · Eden Prairie, MN
Makes a device for people with peripheral neuropathy.
Tactile Systems Technology Inc.
Director
2016 – 2021 · Public company (TCMD)
Cogentix Medical Inc.
Director
2015 · Public company (CGNT)
Uroplasty Inc.
Director
2014 – 2015 · Public company (UPI)
Virtual Radiologic CORP
Director
2008 – 2010 · Public company (VRAD)

Key Colleagues at Startups

The people Kevin Roche works with at each company, as listed on that company's latest Form D.

RxFunction, Inc. · Form D/A, Oct 14, 2026
MA
Mary Anderson
Chief Executive Officer and director
LO
Lars Oddsson
Executive officer and director
RR
Robert Rinek
Director
RN

Sources

  1. SECRxFunction, Inc. Form D/A, filed Oct 14, 2026
  2. SECForms 3, 4 and 5 filed by Kevin Roche (SEC filer 1024356)